Privately-held Immunocore Ltd of the UK has secured its second major licensing deal in less than a month, this time with GlaxoSmithKline Plc to discover bi-specific biological drugs against multipl ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
